[go: up one dir, main page]

DE60111657D1 - Pharmazeutische Zusammensetzung enthaltend Ibuprofen und ein Verfahren zur deren Herstellung - Google Patents

Pharmazeutische Zusammensetzung enthaltend Ibuprofen und ein Verfahren zur deren Herstellung

Info

Publication number
DE60111657D1
DE60111657D1 DE60111657T DE60111657T DE60111657D1 DE 60111657 D1 DE60111657 D1 DE 60111657D1 DE 60111657 T DE60111657 T DE 60111657T DE 60111657 T DE60111657 T DE 60111657T DE 60111657 D1 DE60111657 D1 DE 60111657D1
Authority
DE
Germany
Prior art keywords
preparation
pharmaceutical composition
ibuprofen
composition containing
mixing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60111657T
Other languages
English (en)
Other versions
DE60111657T2 (de
Inventor
Perez Maria Teresa Tarre
Faus Xavier Font
Casas Montserrat Trullols
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorio de Aplicaciones Farmacodinamicas SA
Original Assignee
Laboratorio de Aplicaciones Farmacodinamicas SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorio de Aplicaciones Farmacodinamicas SA filed Critical Laboratorio de Aplicaciones Farmacodinamicas SA
Publication of DE60111657D1 publication Critical patent/DE60111657D1/de
Application granted granted Critical
Publication of DE60111657T2 publication Critical patent/DE60111657T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE60111657T 2000-03-03 2001-03-01 Pharmazeutische Zusammensetzung enthaltend Ibuprofen und ein Verfahren zur deren Herstellung Expired - Lifetime DE60111657T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200000522A ES2171110B1 (es) 2000-03-03 2000-03-03 Composicion farmaceutica a base de ibuprofeno y procedimiento para su preparacion.
ES200000522 2000-03-03

Publications (2)

Publication Number Publication Date
DE60111657D1 true DE60111657D1 (de) 2005-08-04
DE60111657T2 DE60111657T2 (de) 2006-05-04

Family

ID=8492565

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60111657T Expired - Lifetime DE60111657T2 (de) 2000-03-03 2001-03-01 Pharmazeutische Zusammensetzung enthaltend Ibuprofen und ein Verfahren zur deren Herstellung

Country Status (8)

Country Link
EP (1) EP1129709B1 (de)
AT (1) ATE298567T1 (de)
CZ (1) CZ301553B6 (de)
DE (1) DE60111657T2 (de)
DK (1) DK1129709T3 (de)
ES (1) ES2171110B1 (de)
PT (1) PT1129709E (de)
SK (1) SK285338B6 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
CN103622926A (zh) * 2005-11-02 2014-03-12 帝国制药美国公司 感官上可接受的布洛芬口服给药制剂、制备和使用它的方法
EP1840188B1 (de) 2006-03-31 2011-09-07 Sony Deutschland GmbH Zusammensetzung mit mindestens einer Art von Flüssigkristall
ES2303468B1 (es) * 2007-01-22 2009-06-08 Masterfarm, S.L "una composicion farmaceutica pulverulenta que comprende ibuprofeno".
EP1974751A1 (de) * 2007-03-26 2008-10-01 The Jordanian Pharmaceutical Manufacturing Co. Formulierungen für nichtsteroidale entzündungshemmende Arzneimittel
FR2914187B1 (fr) * 2007-03-28 2011-01-21 Pf Medicament Complexes d'ibuprofene, de cyclodextrines et d'agents ternaires, et leurs utilisations en pharmaceutique.
ES2608060T3 (es) 2009-04-27 2017-04-05 Laboratorio De Aplicaciones Farmacodinamicas, S.A. Suspensión oral de Lisinato de Ibuprofeno
TW201038296A (en) * 2009-04-27 2010-11-01 Aplicaciones Farmacodinamicas S A Lab De Ibuprofen lysinate oral suspension
WO2014194872A1 (en) 2013-06-04 2014-12-11 Zentiva, K.S. Taste masking of water soluble drugs using poloxamers
WO2024246565A2 (en) 2023-06-02 2024-12-05 Ioulia Tseti Pharmaceutical composition comprising ibuprofen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813682D0 (en) * 1988-06-09 1988-07-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
DE4038314A1 (de) * 1990-11-30 1992-06-04 Puetter Medice Chem Pharm Komplexe des aktiven enantiomers des ibuprofens mit cyclodextrin
GB9207990D0 (en) * 1992-04-10 1992-05-27 Smithkline Beecham Plc Pharmaceutical composition
GB9316580D0 (en) * 1993-08-10 1993-09-29 Smithkline Beecham Plc Pharmaceutical composition
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
EP1129709A3 (de) 2001-11-14
EP1129709B1 (de) 2005-06-29
CZ301553B6 (cs) 2010-04-14
ES2171110A1 (es) 2002-08-16
ATE298567T1 (de) 2005-07-15
PT1129709E (pt) 2005-10-31
CZ2001714A3 (cs) 2001-10-17
SK2932001A3 (en) 2001-12-03
EP1129709A2 (de) 2001-09-05
ES2171110B1 (es) 2003-06-16
DE60111657T2 (de) 2006-05-04
DK1129709T3 (da) 2005-10-24
SK285338B6 (sk) 2006-11-03

Similar Documents

Publication Publication Date Title
IL157963A0 (en) Hsa-free formulations of interferon-beta
DE59509518D1 (de) Formulierung zur inhalativen applikation
ES2189803T3 (es) Procedimiento.
AU2001279631A1 (en) Self-emulsifying active substance formulation and use of this formulation
ES2126536B1 (es) "preparado farmaceutico para administracion intranasal y procedimientopara su produccion".
FI971776A0 (fi) Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
ES2078994T3 (es) Procedimiento para producir en hojas formas de representacion de descomposicion rapida.
ATE193302T1 (de) Glutathionanaloge und paraloge mischungen aus glutathion-ähnlichen substanzen
ATE275393T1 (de) Feste dispersionen mit nitrataktiven wirkstoffen
DE60111657D1 (de) Pharmazeutische Zusammensetzung enthaltend Ibuprofen und ein Verfahren zur deren Herstellung
HU9400430D0 (en) New pyrazine derivatives, their preparation and pharmaceutical compositions containing them
BR9401199A (pt) Preparados de medicamentos, processo para a preparação de um preparado de medicamento, processo para a preparação de uma formulação de medicamento.
ATE424192T1 (de) Stabile pharmazeutische zubereitungen mit 2-aza- bicyclo 3.3.0 -octan-3-carboxylsäure-derivaten
ATE290858T1 (de) N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin
NO303715B1 (no) Stabilt, vandig apparat
WO2003020214A3 (en) Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
DE69736396D1 (de) Sphärische Teilchen, Verfahren zu deren Herstellung und pharmazeutische ZUsammensetzungen mit diesen
HUT60245A (en) Insecticidal compositions comprising 2-aryl-1-(alkoxymethyl)-4-halogen-5-(trifluoromethyl)-pyrrole derivatives as active ingredient and process for producing the active ingredient
IL163608A (en) Sulfonanilides are conserved in their amino / amino acids and derivatives, their process, their pharmaceutical preparations, and their conjugated antibodies and their use in the preparation of drugs for the treatment of culture disorders
WO2003028624A3 (en) Levothyroxine compositions and methods
JPS5781409A (en) External plaster
ATE301452T1 (de) Verfahren zur herstellung einer flüssigen dosierungseinheit und kit
AU2369801A (en) Pharmaceutical composition for transdermally administering hormones with an additive that enhances permeation
DE69108976D1 (de) Neue Polycarbophil enthaltende pharmazeutische Zusammensetzungen und Verfahren zu deren Herstellung.
WO2004014318A3 (en) Levothyroxine compositions and methods

Legal Events

Date Code Title Description
8364 No opposition during term of opposition